Takura’s executive chairman Per Båtelson presented the group on Stockholm Corporate Finance Financial Hearing today. The presentation and QA is 30 minutes and gives a high level overview of the group.
https://takura.se/wp-content/uploads/2020/10/takura-300x89.png 0 0 Maria Rankka https://takura.se/wp-content/uploads/2020/10/takura-300x89.png Maria Rankka2021-03-23 10:27:562021-03-23 10:27:56TAKURA presents at Financial Hearings
A Biocell Portfolio Development company that commercializes advanced cell therapy research in order to accelerate the development within regenerative medicine and make groundbreaking treatments more accessible and affordable.
- Gunnar Forssell, former strategy lead at Merck, joins Takura 30 juni, 2021
- TAKURA presents at Financial Hearings 23 mars, 2021
- Takura acquires Polybiocept GmbH 14 juli, 2020
- Takura joins forces with Abu Dhabi 26 september, 2019